Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

PURPOSE: Urinary comprehensive genomic profiling (uCGP) uses next-generation sequencing to identify mutations associated with urothelial carcinoma and has the potential to improve patient outcomes by noninvasively diagnosing disease, predicting grade and stage, and estimating recurrence risk. EXPERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Salari, Keyan, Sundi, Debasish, Lee, Jason J., Wu, Shulin, Wu, Chin-Lee, DiFiore, Gabrielle, Yan, Q. Robert, Pienkny, Andrew, Lee, Chi K., Oberlin, Daniel, Barme, Greg, Piser, Joel, Kahn, Robert, Collins, Edward, Phillips, Kevin G., Caruso, Vincent M., Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S., Evans-Holm, Martha E., MacBride, Andrew R., Fischer, Daniel S., Haddadzadeh, Iden J., Mazzarella, Brian C., Gray, Joe W., Koppie, Theresa M., Bicocca, Vincent T., Levin, Trevor G., Lotan, Yair, Feldman, Adam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502470/
https://www.ncbi.nlm.nih.gov/pubmed/37439796
http://dx.doi.org/10.1158/1078-0432.CCR-23-0570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502470/
https://www.ncbi.nlm.nih.gov/pubmed/37439796
http://dx.doi.org/10.1158/1078-0432.CCR-23-0570

Ejemplares similares